Star Combo Pharma Limited (ASX:S66)
Australia · Delayed Price · Currency is AUD 0.1550
+0.0050 (3.33%)
Jun 4, 2026, 3:10 PM AEST
Star Combo Pharma Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 20 | 18 | 15 | 15 | 21 | 34 | |
Market Cap Growth | 42.86% | 22.73% | - | -28.77% | -39.31% | -36.64% |
Enterprise Value | 7 | 9 | 10 | 10 | 10 | 18 |
Last Close Price | 0.15 | 0.13 | 0.11 | 0.11 | 0.15 | 0.25 |
PE Ratio | 4.91 | 4.58 | 19.88 | - | - | - |
PS Ratio | 0.84 | 0.66 | 0.57 | 0.60 | 0.91 | 1.27 |
PB Ratio | 0.52 | 0.48 | 0.44 | 0.45 | 0.59 | 0.95 |
P/TBV Ratio | 0.53 | 0.49 | 0.46 | 0.46 | 0.60 | 1.02 |
P/FCF Ratio | 3.35 | 1.58 | - | - | - | - |
P/OCF Ratio | 3.09 | 1.53 | - | 7.92 | 39.07 | 103.68 |
EV/Sales Ratio | 0.27 | 0.34 | 0.38 | 0.42 | 0.45 | 0.65 |
EV/EBITDA Ratio | 0.92 | 1.42 | 5.76 | 6.40 | 28.43 | - |
EV/EBIT Ratio | 1.30 | 1.88 | 10.80 | 9.28 | - | - |
EV/FCF Ratio | 1.08 | 0.82 | - | - | - | - |
Debt / Equity Ratio | 0.11 | 0.10 | 0.12 | 0.13 | 0.12 | 0.09 |
Debt / EBITDA Ratio | 0.60 | 0.57 | 2.03 | 2.57 | 6.96 | - |
Debt / FCF Ratio | 0.71 | 0.34 | - | - | - | - |
Net Debt / Equity Ratio | -0.36 | -0.37 | -0.10 | -0.16 | -0.18 | -0.39 |
Net Debt / EBITDA Ratio | -2.02 | -2.14 | -1.92 | -3.25 | -17.13 | 9.13 |
Net Debt / FCF Ratio | -2.30 | -1.23 | 1.89 | 6.24 | 0.93 | 2.03 |
Asset Turnover | 0.53 | 0.61 | 0.61 | 0.58 | 0.53 | 0.55 |
Inventory Turnover | 4.44 | 3.81 | 3.85 | 4.16 | 3.81 | 4.76 |
Quick Ratio | 5.57 | 3.50 | 2.43 | 3.13 | 3.28 | 5.61 |
Current Ratio | 6.64 | 4.40 | 3.77 | 4.18 | 4.76 | 7.45 |
Return on Equity (ROE) | 14.86% | 14.63% | 2.24% | -11.66% | -1.94% | -19.52% |
Return on Assets (ROA) | 6.96% | 6.85% | 1.36% | 1.64% | -0.09% | -2.53% |
Return on Invested Capital (ROIC) | 20.01% | 18.21% | 2.37% | 3.93% | -0.25% | -8.67% |
Return on Capital Employed (ROCE) | 11.60% | 11.70% | 2.40% | 3.00% | -0.20% | -5.00% |
Earnings Yield | 20.32% | 28.78% | 5.03% | -26.94% | -3.34% | -22.91% |
FCF Yield | 29.81% | 63.32% | -11.83% | -5.71% | -32.41% | -20.15% |
Dividend Yield | 2.47% | 2.79% | 3.50% | - | - | - |
Payout Ratio | 9.28% | 9.53% | - | - | - | - |
Buyback Yield / Dilution | 2.39% | - | - | -0.37% | 0.15% | -47.45% |
Total Shareholder Return | 4.85% | 2.79% | 3.50% | -0.37% | 0.15% | -47.45% |